Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rezolute, Inc. Director's Dealing 2017

Jan 25, 2017

32362_dirs_2017-01-24_8c23225d-6c45-458a-b0e8-b95c85267e43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2017-01-18

Reporting Person: Welch David F (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-18 Common Stock P 5000 $1.00 Acquired 1771432 Indirect
2017-01-19 Common Stock P 10000 $.95 Acquired 1781432 Indirect
2017-01-20 Common Stock P 9983 $1.07 Acquired 1791415 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15000 Direct

Footnotes

F1: The Reporting Person is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock owned by LRFA, LLC.